Tag Archives: PFE

Pfizer (PFE) Receives a Hold from Barclays

Barclays analyst Geoff Meacham maintained a Hold rating on Pfizer (PFE – Research Report) yesterday and set a price target of $41. The company’s shares opened today at $40.30. According to TipRanks.com, Meacham is a 4-star analyst with an average

Pfizer (PFE) Received its Third Buy in a Row

After Credit Suisse and Merrill Lynch gave Pfizer (NYSE: PFE) a Buy rating last month, the company received another Buy, this time from Cantor Fitzgerald. Analyst Louise Chen reiterated a Buy rating on Pfizer today and set a price target

Pfizer (PFE) Gets a Hold Rating from J.P. Morgan

J.P. Morgan analyst Chris Schott maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $46. The company’s shares closed yesterday at $39.38. According to TipRanks.com, Schott has 0 stars on 0-5 star

Cantor Fitzgerald Sticks to Their Buy Rating for Pfizer (PFE)

Cantor Fitzgerald analyst Louise Chen reiterated a Buy rating on Pfizer (PFE – Research Report) today and set a price target of $53. The company’s shares closed on Friday at $42.40. Chen observed: “We reiterate our OW rating and think

The President R&D of Pfizer is Exercising Options

Yesterday it was reported that the President R&D of Pfizer (PFE – Research Report), Mikael Dolsten, exercised options to buy 309,462 PFE shares at $30.75 a share, for a total transaction value of $9.52M. This recent transaction increases Mikael Dolsten’s

Pfizer (PFE) Gets a Buy Rating from Cantor Fitzgerald

In a report released today, Louise Chen from Cantor Fitzgerald reiterated a Buy rating on Pfizer (PFE – Research Report), with a price target of $53. The company’s shares opened today at $44.08. Chen noted: “We reiterate our OW and